
Rapastinel acetate
CAS No. 491872-39-0
Rapastinel acetate( Rapastinel acetate (117928-94-6 Free base) )
Catalog No. M28008 CAS No. 491872-39-0
Rapastinel acetate is a modulator of N-methyl-D-aspartate (NMDA) receptor and a partial agonist of glycine site long-lasting antidepressant effects.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
![]() ![]() |
10MG | 581 | Get Quote |
![]() ![]() |
25MG | 888 | Get Quote |
![]() ![]() |
50MG | 1242 | Get Quote |
![]() ![]() |
100MG | 1674 | Get Quote |
![]() ![]() |
500MG | 3348 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameRapastinel acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionRapastinel acetate is a modulator of N-methyl-D-aspartate (NMDA) receptor and a partial agonist of glycine site long-lasting antidepressant effects.
-
DescriptionRapastinel acetate is a modulator of N-methyl-D-aspartate (NMDA) receptor and a partial agonist of glycine site long-lasting antidepressant effects.(In Vivo):Rapastinel acetate (3mg/kg; i.v.) facilitated long-term potentiation (LTP) 1day-2weeks but not 4weeks post-dosing. Biweekly dosing with Rapastinel acetate sustained this effect for at least 8weeks. A single dose of Rapastinel acetate increased the proportion of whole-cell NMDAR current contributed by NR2B-containing NMDARs in the hippocampus 1week post-dosing, which returned to baseline by 4weeks post-dosing.
-
In Vitro——
-
In Vivo——
-
SynonymsRapastinel acetate (117928-94-6 Free base)
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
RecptorLipid|Mitochondria|iron chelator
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number491872-39-0
-
Formula Weight473.52
-
Molecular FormulaC20H35N5O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C)(O)=O.C(=O)([C@H]1N(C([C@H]([C@@H](C)O)N)=O)CCC1)N2[C@H](C(N[C@@H]([C@@H](C)O)C(N)=O)=O)CCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shachar DB, et al. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology. 2004 Feb;46(2):254-63.
molnova catalog



related products
-
AV-101
AV-101 (4-Cl-KYN) , a prodrug antagonist at the glycine site of the NMDA receptor, has antidepressant activity and reduces levodopa-induced dyskinesia in MPTP monkeys.
-
ALDH3A1-IN-1
ALDH3A1-IN-1 (Compound 18) is a potent ALDH3A1 inhibitor with an IC 50 of 1.61 μM. It is more effective than DEAB against patient-derived primary prostate tumor epithelial cells, both as a single agent and in combination with docetaxel .
-
Lanicemine dihydroch...
Lanicemine dihydrochloride (AZD-6765 dihydrochloride) is a low-capture NMDA channel blocker with antidepressant activity and can be used to study neurological diseases.